Detalhe da pesquisa
1.
NitroprussideâExpanding the Potential Use of an Old Drug Using Nanoparticles.
Mol Pharm
; 20(1): 6-22, 2023 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36350781
2.
Pentacyanoferrate(II) complex of pyridine-4- and pyrazine-2-hydroxamic acid as source of HNO: investigation of anti-tubercular and vasodilation activities.
J Biol Inorg Chem
; 25(6): 887-901, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32728907
3.
Antimicrobial activity and antibiotic synergy of a biphosphinic ruthenium complex against clinically relevant bacteria.
Biofouling
; 36(4): 442-454, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32447980
4.
Aryl-Substituted Ruthenium(II) Complexes: A Strategy for Enhanced Photocleavage and Efficient DNA Binding.
Inorg Chem
; 56(15): 9084-9096, 2017 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28726387
5.
New nitrosyl ruthenium complexes with combined activities for multiple cardiovascular disorders.
Dalton Trans
; 52(16): 5176-5191, 2023 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36970749
6.
Isoniazid metal complex reactivity and insights for a novel anti-tuberculosis drug design.
J Biol Inorg Chem
; 17(2): 275-83, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21952749
7.
Synthesis and potential vasorelaxant effect of a novel ruthenium-based nitro complex.
J Inorg Biochem
; 228: 111666, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34923187
8.
The biofilm inhibition activity of a NO donor nanosilica with enhanced antibiotics action.
Int J Pharm
; 610: 121220, 2021 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34687814
9.
Anti-asthmatic effect of nitric oxide metallo-donor FOR811A [cis-[Ru(bpy)2(2-MIM)(NO)](PF6)3] in the respiratory mechanics of Swiss mice.
PLoS One
; 16(3): e0248394, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33711054
10.
Antihypertensive potential of cis-[Ru(bpy)2(ImN)(NO)]3+, a ruthenium-based nitric oxide donor.
Res Vet Sci
; 130: 153-160, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32193002
11.
Nitro-imidazole-based ruthenium complexes with antioxidant and anti-inflammatory activities.
J Inorg Biochem
; 206: 111048, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32151873
12.
A divergent mode of activation of a nitrosyl iron complex with unusual antiangiogenic activity.
J Inorg Biochem
; 210: 111133, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32619898
13.
In vitro and in vivo leishmanicidal activity of a ruthenium nitrosyl complex against Leishmania (Viannia) braziliensis.
Acta Trop
; 192: 61-65, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30689977
14.
Oxygen-sensing histidine-protein kinases: assays of ligand binding and turnover of response-regulator substrates.
Methods Enzymol
; 437: 173-89, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18433629
15.
Synthesis and mechanistic investigation of iron(II) complexes of isoniazid and derivatives as a redox-mediated activation strategy for anti-tuberculosis therapy.
J Inorg Biochem
; 179: 71-81, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29175704
16.
DosT and DevS are oxygen-switched kinases in Mycobacterium tuberculosis.
Protein Sci
; 16(8): 1708-19, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17600145
17.
A proximal arginine R206 participates in switching of the Bradyrhizobium japonicum FixL oxygen sensor.
J Mol Biol
; 360(1): 80-9, 2006 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-16813836
18.
Drug discovery targeting heme-based sensors and their coupled activities.
J Inorg Biochem
; 167: 12-20, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27893989
19.
[Fe(CN)5(isoniazid)](3-): an iron isoniazid complex with redox behavior implicated in tuberculosis therapy.
J Inorg Biochem
; 140: 236-44, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25189361
20.
Activity of IQG-607, a new orally active compound, in a murine model of Mycobacterium tuberculosis infection.
Int J Antimicrob Agents
; 40(2): 182-5, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22748570